Chronic Traumatic Encephalopathy is a progressive neurodegenerative disease associated with repetitive traumatic brain injury (TBI), most commonly seen in contact sport athletes and military veterans. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease caused by repetitive traumatic brain injury (TBI), most commonly associated with contact sports, military service, and physical abuse[@mckee2009]. CTE is characterized by the accumulation of hyperphosphorylated tau (p-tau) protein in the form of neurofibrillary tangles (NFTs), predominantly affecting cortical neurons and leading to progressive cognitive, behavioral, and motor impairments[@omalu2005].
Epidemiology and Risk Factors
Prevalence
CTE has been predominantly identified in individuals with a history of repetitive mild traumatic brain injuries:
Contact sport athletes: American football players, boxers, hockey players, soccer players, and rugby players show the highest prevalence
Military veterans: Those exposed to blast injuries and repetitive concussive events
Physical abuse victims: Individuals with a history of repeated head trauma
...
Chronic Traumatic Encephalopathy (CTE)
Overview
Chronic Traumatic Encephalopathy is a progressive neurodegenerative disease associated with repetitive traumatic brain injury (TBI), most commonly seen in contact sport athletes and military veterans. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease caused by repetitive traumatic brain injury (TBI), most commonly associated with contact sports, military service, and physical abuse[@mckee2009]. CTE is characterized by the accumulation of hyperphosphorylated tau (p-tau) protein in the form of neurofibrillary tangles (NFTs), predominantly affecting cortical neurons and leading to progressive cognitive, behavioral, and motor impairments[@omalu2005].
Epidemiology and Risk Factors
Prevalence
CTE has been predominantly identified in individuals with a history of repetitive mild traumatic brain injuries:
Contact sport athletes: American football players, boxers, hockey players, soccer players, and rugby players show the highest prevalence
Military veterans: Those exposed to blast injuries and repetitive concussive events
Physical abuse victims: Individuals with a history of repeated head trauma
The disease typically manifests decades after the period of repetitive brain trauma, with onset usually occurring in middle to late adulthood[@mez2017]. A 2017 study of 202 former American football players found CTE in 177 (87%) of brains donated to the CTE Center at Boston University.
Risk Factors
Duration of exposure: Number of years participating in contact sports
Number of concussions: Total lifetime concussive and subconcussive impacts
Age of first exposure: Earlier age of initial head trauma exposure correlates with worse outcomes
Genetic factors: APOE ε4 allele may increase susceptibility[@mayeux2015]
Pathophysiology
Tau Pathology
CTE is defined pathologically by the presence of hyperphosphorylated tau protein NFTs in a pattern distinct from other tauopathies[@mckee2013]:
Distribution: Initially affects the superficial cortical layers (II-III), then spreads to deeper layers
Regional pattern: Preferentially affects frontal and temporal cortices, with relative sparing of the hippocampus early in disease
Perivascular pattern: p-tau aggregates around blood vessels, particularly in the depths of cortical sulci
Astrocytic tau: Astrocytic tau pathology is a characteristic feature
Mechanistic Pathways
Mermaid diagram (expand to render)
Molecular Mechanisms
Axonal damage: Mechanical disruption of microtubules leads to impaired axonal transport
Neuroinflammation: Chronic microglial activation and neuroinflammation
Blood-brain barrier disruption: Increased permeability following repeated injuries
Tau kinases activation: Chronic activation of GSK-3β, CDK5, and MAPK pathways
Oxidative stress: Increased reactive oxygen species generation following repeated injuries
Excitotoxicity: Release of excitatory neurotransmitters leads to calcium influx and neuronal dysfunction
Amyloid Co-Pathology
While CTE is primarily a tauopathy, approximately 20-50% of CTE cases also show co-existing amyloid-beta plaques, similar to Alzheimer's disease. This overlap suggests common pathogenic mechanisms or that repetitive brain trauma may accelerate Alzheimer's-type pathology in susceptible individuals.
Clinical Presentation
Clinical Staging
CTE symptoms typically develop years to decades after the period of repetitive brain trauma:
| Stage | Symptoms | |-------|----------| | Stage I | Headache, attention deficits, irritability, mood changes | | Stage II | Memory loss, impulsivity, aggression, anxiety | | Stage III | Severe memory loss, parkinsonism, speech abnormalities | | Stage IV | Dementia, severe motor impairment, psychosis |
Cognitive Impairments
Memory loss and difficulty forming new memories
Executive dysfunction and impaired judgment
Attention and concentration deficits
Progressive dementia
Behavioral Changes
Mood swings and irritability
Depression and anxiety
Impulse control problems
Aggression and explosive temper
Suicidal ideation
Motor Symptoms
Parkinsonism and gait disturbances
Dysarthria (slurred speech)
Muscle weakness and atrophy
Tremor and rigidity
Other Features
Chronic traumatic encephalomyelopathy (CTEM): Combined tau and motor neuron pathology
Progressive dysphagia (difficulty swallowing)
Sleep disturbances including REM sleep behavior disorder
Diagnosis
Clinical Criteria
Currently, CTE can only be diagnosed definitively at autopsy. Proposed clinical criteria include:
History: Documented exposure to repetitive brain trauma
| Center | Location | |--------|----------| | BU CTE Center | Boston University | | VA-BU-CLF Brain Bank | Boston, MA | | NIH CTE Program | National Institutes of Health |
Emerging Therapies
Tau immunotherapy: Active and passive immunization against tau
Tau aggregation inhibitors: Small molecules targeting p-tau formation
[McKee et al., The spectrum of disease in chronic traumatic encephalopathy (2013)](https://pubmed.ncbi.nlm.nih.gov/23333407/). Brain. 2013;136(Pt 1):43-64.
[Mez et al., Clinicopathological Evaluation of CTE in Players of American Football (2017)](https://pubmed.ncbi.nlm.nih.gov/28679853/). JAMA. 2017;318(4):360-370.
[Stein et al., Chronic traumatic encephalopathy: a spectrum of neuropathological changes (2014)](https://pubmed.ncbi.nlm.nih.gov/24439377/). Acta Neuropathol. 2014;127(1):13-15.
[Stern et al., Clinical Presentation of CTE (2013)](https://pubmed.ncbi.nlm.nih.gov/23474771/). Neurology. 2013;81(13):1122-1129.
[Turner et al., Defining the Spectrum of Long-Term sequelae (2021)](https://doi.org/10.1212/WNL.0000000000013050)
Recent Research (2024-2026)
[Inflammation, Limbic White Matter Microstructure, and Clinical Symptoms in Retired American Football Players (2026)](https://pubmed.ncbi.nlm.nih.gov/41740080/) - Neurology
[Retired contact sports athletes with cognitive concerns: promoting lifelong brain health (2026)](https://pubmed.ncbi.nlm.nih.gov/41062271/) - Practical neurology
[On media and messaging: fighting fear with facts as the science of CTE evolves (2026)](https://pubmed.ncbi.nlm.nih.gov/41571435/) - British Journal of Sports Medicine
[Motivation and methods for a first population-based case-control study of TBI and CTE (2026)](https://pubmed.ncbi.nlm.nih.gov/40987505/) - British Journal of Sports Medicine
[Effect of site-specific lysine acetylation on tau binding to microtubules (2026)](https://pubmed.ncbi.nlm.nih.gov/41738377/) - Physical Chemistry Chemical Physics
[Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
[BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data
References
[McKee et al., Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19587364/)
[Omalu et al., Chronic traumatic encephalopathy in a National Football League player (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15959414/)
[Mez et al., Clinicopathological Evaluation of CTE in Players of American Football (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28679853/)
[Unknown, Mayeux and Schupf, Apolipoprotein E and Alzheimer's disease (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25993323/)
[McKee et al., The spectrum of disease in CTE (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23333407/)
[Blennow et al., Neurobiology of CTE (2016) (2016)](https://doi.org/10.1016/S1474-4422(16)
[Kelley et al., Tau pathology in CTE (2022) (2022)](https://doi.org/10.1002/alz.12608)
[Washington et al., CTE Neuropathology (2022) (2022)](https://doi.org/10.1007/s00401-022-02408-3)
[Alosco et al., Clinical phenotype of CTE (2018) (2018)](https://doi.org/10.1212/WNL.0000000000005518)
[Mez et al., Association between American football playing and CTE (2020) (2020)](https://doi.org/10.1001/jama.2019.21096)